These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37769507)

  • 1. Usefulness of glucose management indicator derived from continuous glucose monitoring to assess glycemic condition in hospitalized patients with diabetic kidney disease treated with insulin pumps.
    Lu Y; Zhang Q; Wang X; Jiang Y; Xue Y
    J Diabetes Complications; 2023 Nov; 37(11):108613. PubMed ID: 37769507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of HbA1c and glucose management indicator discordance in a population of children and adolescents with type 1 diabetes.
    Piona C; Marigliano M; Mozzillo E; Di Candia F; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Piccinno E; Maffeis C
    Pediatr Diabetes; 2022 Feb; 23(1):84-89. PubMed ID: 34888998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discordance Between Glycated Hemoglobin A1c and the Glucose Management Indicator in People With Diabetes and Chronic Kidney Disease.
    Oriot P; Viry C; Vandelaer A; Grigioni S; Roy M; Philips JC; Prévost G
    J Diabetes Sci Technol; 2023 Nov; 17(6):1553-1562. PubMed ID: 35466719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Flash Glucose Monitoring and Glycemic Control in Patients with Type 2 Diabetes Mellitus Not Treated with an Intensive Insulin Regimen: 1-Year Real-Life Retrospective Cohort Study.
    Al Hayek AA; Al Dawish MA
    Adv Ther; 2023 Jun; 40(6):2855-2868. PubMed ID: 37133646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Examination of the Glucose Management Indicator in Young Children with Type 1 Diabetes.
    Monzon AD; Patton SR; Clements M
    J Diabetes Sci Technol; 2022 Nov; 16(6):1505-1512. PubMed ID: 34098763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of self-monitoring of blood glucose versus retrospective continuous glucose monitoring in improving glycaemic control in diabetic kidney disease patients.
    Yeoh E; Lim BK; Fun S; Tong J; Yeoh LY; Sum CF; Subramaniam T; Lim SC
    Nephrology (Carlton); 2018 Mar; 23(3):264-268. PubMed ID: 27933715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discordance Between Glucose Management Indicator and Glycated Hemoglobin in People Without Diabetes.
    Shah VN; Vigers T; Pyle L; Calhoun P; Bergenstal RM
    Diabetes Technol Ther; 2023 May; 25(5):324-328. PubMed ID: 36790875
    [No Abstract]   [Full Text] [Related]  

  • 8. Glucose Management Indicator for People with Type 1 Asian Diabetes Is Different from That of the Published Equation: Differences by Glycated Hemoglobin Distribution.
    Yoo JH; Yang SH; Kim G; Kim JH
    Diabetes Technol Ther; 2021 Nov; 23(11):745-752. PubMed ID: 34160289
    [No Abstract]   [Full Text] [Related]  

  • 9. Usefulness of CGM-Derived Metric, the Glucose Management Indicator, to Assess Glycemic Control in Non-White Individuals With Diabetes.
    Toschi E; Michals A; Adam A; Davis D; Atakov-Castillo A; Slyne C; Munshi M
    Diabetes Care; 2021 Dec; 44(12):2787-2789. PubMed ID: 34635503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of the Glucose Management Indicator (GMI) in Type 2 Diabetes.
    Fang M; Wang D; Rooney MR; Echouffo-Tcheugui JB; Coresh J; Aurora RN; Punjabi NM; Selvin E
    Clin Chem; 2023 Apr; 69(4):422-428. PubMed ID: 36738249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Discrepancy Between Hemoglobin A1c and Glucose Management Indicators in 26 Patients Treated With Continuous Glucose Monitoring in an Internal Medicine Residency Clinic.
    Manov AE; Holt N; Dini E; Rivera R; Donepudi A; Haddadin R; Mefferd K; Qadir I
    Cureus; 2024 Mar; 16(3):e56768. PubMed ID: 38650779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved Estimation of Glycated Hemoglobin from Continuous Glucose Monitoring and Past Glycated Hemoglobin Data.
    Chrzanowski J; Michalak A; Łosiewicz A; Kuśmierczyk H; Mianowska B; Szadkowska A; Fendler W
    Diabetes Technol Ther; 2021 Apr; 23(4):293-305. PubMed ID: 33112161
    [No Abstract]   [Full Text] [Related]  

  • 13. HbA1c and Glucose Management Indicator Discordance: A Real-World Analysis.
    Perlman JE; Gooley TA; McNulty B; Meyers J; Hirsch IB
    Diabetes Technol Ther; 2021 Apr; 23(4):253-258. PubMed ID: 33253015
    [No Abstract]   [Full Text] [Related]  

  • 14. The Glucose Management Indicator: Time to Change Course?
    Selvin E
    Diabetes Care; 2024 Jun; 47(6):906-914. PubMed ID: 38295402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous Glucose Monitoring Metrics and Hemoglobin A1c Relationship in Patients with Type 2 Diabetes Treated by Hemodialysis.
    Galindo RJ; Moazzami B; Tuttle KR; Bergenstal RM; Peng L; Umpierrez GE
    Diabetes Technol Ther; 2024 Nov; 26(11):862-868. PubMed ID: 38805310
    [No Abstract]   [Full Text] [Related]  

  • 16. The Calculation of the Glucose Management Indicator Is Influenced by the Continuous Glucose Monitoring System and Patient Race.
    Angellotti E; Muppavarapu S; Siegel RD; Pittas AG
    Diabetes Technol Ther; 2020 Sep; 22(9):651-657. PubMed ID: 31821016
    [No Abstract]   [Full Text] [Related]  

  • 17. The potential of glucose management indicator for the estimation of glucose disposal rate in people with type 1 diabetes.
    Cutruzzolà A; Parise M; Scavelli FB; Fiorentino R; Lucà S; Di Molfetta S; Gnasso A; Irace C
    Nutr Metab Cardiovasc Dis; 2024 Oct; 34(10):2344-2352. PubMed ID: 39069471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship Between Time-in-Range, HbA1c, and the Glucose Management Indicator in Pregnancies Complicated by Type 1 Diabetes.
    Shah VN; Snell-Bergeon JK; Demmitt JK; Joshee P; Garcetti R; Pyle L; Polsky S
    Diabetes Technol Ther; 2021 Dec; 23(12):783-790. PubMed ID: 34524020
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.